Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    23048052 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome
Conditions: Myocardial Infarction;   Coronary Disease
Interventions: Drug: Abciximab + UFH;   Drug: Bivalirudin;   Drug: Heparin
2 Completed Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
Conditions: Unstable Angina;   Myocardial Infarction;   Acute Disease
Intervention: Drug: Angiomax (bivalirudin) anticoagulant

Indicates status has not been verified in more than two years